Oculis' OCS-01 eye drops, currently in phase 3 trials for diabetic macular edema, can be an alternative to injection, CEO says Hong Kong could be one of the first jurisdictions to use a novel ...

VEGF is a mediator in the pathogenesis of certain eye conditions, including wet age-related macular degeneration (AMD), diabetic retinopathy and macular oedema secondary to retinal vein occlusions.

Bayer HealthCare's Eylea (aflibercept solution for injection into the eye) has been approved by the European Commission for the treatment of visual impairment due to diabetic macular oedema (DMO).

Safety and the mean change in best-corrected visual acuity (BCVA) from baseline to week 52 in the study eye, measured using .

Diabetic macular edema (DME), a condition causing fluid buildup in the eye’s central retina ... detailed vision. This swelling distorts sight, compromising daily activities like reading and ...